(Q35229164)

7 August 2017

1 reference

title

Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes (English)

1 reference

7 August 2017

Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes (English)

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

therapy-related acute myeloid leukemia

5 December 2023

main subject

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

5 December 2023

author name string

M. J. Ratain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318741

12 September 2022

J. D. Rowley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318741

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1318741

12 September 2022

publication date

1 February 1992

1 reference

full work available at URL

7 August 2017

http://annonc.oxfordjournals.org/cgi/content/abstract/3/2/107

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318741

https://academic.oup.com/annonc/article-pdf/3/2/107/530202/3-2-107.pdf

12 September 2022

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318741

https://api.elsevier.com/content/article/PII:S0923753419651501?httpAccept=text/xml

5 December 2023

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

https://api.elsevier.com/content/article/PII:S0923753419651501?httpAccept=text/plain

5 December 2023

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

http://academic.oup.com/annonc/article-pdf/3/2/107/530202/3-2-107.pdf

5 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

5 December 2023

1 reference

7 August 2017

3

1 reference

7 August 2017

107-111

1 reference

7 August 2017

2

1 reference

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

7 August 2017

4

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Therapy of secondary acute nonlymphocytic leukemia with cytarabine

5 December 2023

7

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

5 December 2023

8

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

5 December 2023

10

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Melphalan may be a more potent leukemogen than cyclophosphamide

5 December 2023

11

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

5 December 2023

12

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Leukemia following chemotherapy for ovarian cancer.

5 December 2023

13

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Leukemia following Hodgkin's disease

5 December 2023

14

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

5 December 2023

16

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Myeloid neoplasia in children treated for solid tumours.

5 December 2023

17

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

5 December 2023

18

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

A possible specific chromosome marker for monocytic leukemia: three more patients with t(9;11)(p22;q24) and another with t(11;17)(q24;q21), each with acute monoblastic leukemia

5 December 2023

19

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma

5 December 2023

20

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs

5 December 2023

21

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

5 December 2023

22

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Chromosomal differences between acute nonlymphocytic leukemia in patients with prior solid tumors and prior hematologic malignancies. A study of 14 cases with prior breast cancer

5 December 2023

23

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation

5 December 2023

24

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report

5 December 2023

25

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

11q23 abnormalities in children with acute nonlymphocytic leukemia (M4–M5)

5 December 2023

26

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

5 December 2023

27

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Leukemia following treatment of germ cell tumors in men.

5 December 2023

31

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Chest wall tumors in infancy and childhood

5 December 2023

32

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Prolonged survival in patients with treatment-related leukemia.

5 December 2023

33

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer

5 December 2023

34

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells

5 December 2023

35

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells

5 December 2023

36

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells

5 December 2023

37

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells

5 December 2023

38

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Mutagenicity of actinomycin D in mammalian cells due to clastogenic effects

5 December 2023

39

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA.

5 December 2023

40

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Clastogenic action of ellipticine over the cell cycle of human lymphocytes and influence of posttreatments with caffeine and ara-C at G2

5 December 2023

41

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

DNA topoisomerases and models of sister-chromatid exchange

5 December 2023

42

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Effects of inhibitors of DNA synthesis on spontaneous and ultraviolet light-induced sister-chromatid exchanges in Chinese hamster cells

5 December 2023

44

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene

5 December 2023

47

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.

5 December 2023

48

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Chromosome aberrations induced by etoposide (VP-16) are not random

5 December 2023

50

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia

5 December 2023

51

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Localization of the human NCAM gene to band q23 of chromosome 11: the third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11

5 December 2023

53

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Chromosomal localization of the human Thy-1 gene

5 December 2023

55

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Chromosomal localization of the human proto-oncogene c-ets

5 December 2023

56

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.

5 December 2023

57

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

Constitutive fragile sites and cancer.

5 December 2023

58

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058121

5 December 2023

Identifiers

1 reference

7 August 2017

1 reference